Druggable targets and therapeutic development for COVID-19
Coronavirus disease (COVID-19), which is caused by SARS-CoV-2, is the biggest challenge to the global public health and economy in recent years. Until now, only limited therapeutic regimens have been available for COVID-19 patients, sparking unprecedented efforts to study coronavirus biology. The ge...
| Главные авторы: | , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
Frontiers Media S.A.
2022-10-01
|
| Серии: | Frontiers in Chemistry |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fchem.2022.963701/full |